This company has been acquired
Science 37 Holdings Management
Management criteria checks 2/4
Science 37 Holdings' CEO is Dave Coman, appointed in Nov 2019, has a tenure of 4.33 years. total yearly compensation is $8.06M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 0.89% of the company’s shares, worth $309.55K. The average tenure of the management team and the board of directors is 3.3 years and 2.4 years respectively.
Key information
Dave Coman
Chief executive officer
US$8.1m
Total compensation
| CEO salary percentage | 6.82% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.9% |
| Management average tenure | 3.3yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$125m |
| Jun 30 2023 | n/a | n/a | -US$134m |
| Mar 31 2023 | n/a | n/a | -US$121m |
| Dec 31 2022 | US$8m | US$550k | -US$51m |
| Sep 30 2022 | n/a | n/a | -US$50m |
| Jun 30 2022 | n/a | n/a | -US$41m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$8m | US$435k | -US$94m |
| Sep 30 2021 | n/a | n/a | -US$42m |
| Jun 30 2021 | n/a | n/a | -US$35m |
| Mar 31 2021 | n/a | n/a | -US$33m |
| Dec 31 2020 | US$1m | US$400k | -US$32m |
Compensation vs Market: Dave's total compensation ($USD8.06M) is above average for companies of similar size in the US market ($USD662.89K).
Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.
CEO
Dave Coman (53 yo)
Mr. David Coman, also known as Dave, has been Chief Executive Officer of Science 37 Holdings, Inc. (formerly known as Science 37, Inc.) since November 2019 and serves as its Director since October 2021. He...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 4.3yrs | US$8.06m | 0.89% $ 309.5k | |
| Chief Legal & Human Resources Officer and Secretary | 2.7yrs | US$4.65m | 0.24% $ 83.4k | |
| Chief Delivery Officer | 4.2yrs | US$3.93m | 0.26% $ 90.6k | |
| Chief Financial Officer | 3.9yrs | no data | 0.15% $ 52.2k | |
| VP and Head of Quality Assurance & Compliance | less than a year | no data | no data | |
| Vice President of Marketing & Communications | 3.8yrs | no data | no data | |
| Chief Strategy & Marketing Officer | no data | no data | no data | |
| Chief Medical Officer | 4.8yrs | US$486.60k | 0.69% $ 240.9k | |
| Chief Commercial Officer | 1.5yrs | no data | 0.059% $ 20.4k | |
| VP of Corporate Strategy & Chief of Staff | 2.2yrs | no data | no data | |
| Senior VP of Patient & Provider Networks | less than a year | no data | no data |
Experienced Management: SNCE's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.4yrs | US$8.06m | 0.89% $ 309.5k | |
| Independent Director | 3.5yrs | US$180.00k | 0.034% $ 11.8k | |
| Independent Chairman of the Board | 2.4yrs | US$215.00k | 0.034% $ 11.8k | |
| Independent Director | 1.5yrs | US$93.33k | 0.038% $ 13.2k | |
| Independent Director | 2.4yrs | no data | no data | |
| Independent Director | 2.4yrs | US$165.00k | 0.034% $ 11.8k | |
| Independent Director | 2.4yrs | US$185.00k | 0.034% $ 11.8k |
Experienced Board: SNCE's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/11 22:23 |
| End of Day Share Price | 2024/03/11 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Science 37 Holdings, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Coldwell | Baird |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Frank Takkinen | Lake Street Capital Markets, LLC |